{"id":6965,"date":"2022-03-29T16:46:45","date_gmt":"2022-03-29T16:46:45","guid":{"rendered":"https:\/\/live-cancer-factfinder.pantheonsite.io\/fact-finder-tool\/antitranspiran\/"},"modified":"2026-10-20T15:46:17","modified_gmt":"2026-10-20T15:46:17","slug":"antitranspiran","status":"publish","type":"post","link":"https:\/\/cancerfactfinder.org\/ht\/zouti-pou-cheche-enfomasyon\/antitranspiran\/","title":{"rendered":"AFIKASYON: Antitranspiran ak dezodoran ogmante risk pou kans\u00e8 nan tete"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\" id=\"what-you-may-have-heard\">Sa ou ka tande<\/h2>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Antitranspiran ak dezodoran gen sibstans ki lak\u00f2z kans\u00e8 epi ki abs\u00f2be, sitou apre ou fin f\u00e8 bab.  <\/span><\/p>\n\n<h2 class=\"wp-block-heading\" id=\"what-science-tells-us\">Sa syans di nou<\/h2>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Antitranspiran yo klase k\u00f2m yon medikaman ki ede diminye kantite swe ki pwodui. Glann ekrin lan pwodui swe epi antitranspiran yo ka bloke pwodiksyon swe a l\u00e8 l s\u00e8vi av\u00e8k yon pwodui ki baze sou aliminy\u00f2m (<\/span> <a href=\"https:\/\/www.webmd.com\/skin-problems-and-treatments\/difference-between-deodorant-and-antiperspirant\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">WebMD<\/span><\/a> <span style=\"font-weight: 400;\">). Deodoran yo itilize pou anpeche oswa maske od\u00e8 k\u00f2. Syantis yo ap etidye si pafen, pr\u00e9servatif, ak l\u00f2t engredyan nan antitranspiran ak deodoran ka ogmante risk kans\u00e8 nan tete. Kesyon sou si gen yon diferans nan risk pou fanm ki raze anba bra yo oswa ki itilize pwodui antitranspiran oswa deodoran ki gen aliminy\u00f2m yo toujou anba rech\u00e8ch.<\/span><br\/><\/p>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Deodoran natir\u00e8l yo vante t\u00e8t yo k\u00f2msi yo pi bon pou moun pase deodoran tradisyon\u00e8l yo. Sepandan, pa gen okenn pr\u00e8v ki montre ke deodoran regilye yo pi mal pou sante w pase deodoran natir\u00e8l yo (<\/span> <a href=\"https:\/\/www.nytimes.com\/2021\/06\/09\/well\/live\/natural-deodorant-questions.html?referringSource=articleShare\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NY Times<\/span><\/a> <span style=\"font-weight: 400;\">). Epitou, engredyan ki nan deodoran natir\u00e8l yo pa pi bon pou mikwoby\u00f2m ou an epi yo ka mwens efikas pase deodoran tradisyon\u00e8l yo (<\/span> <a href=\"https:\/\/www.nytimes.com\/2021\/06\/09\/well\/live\/natural-deodorant-questions.html?referringSource=articleShare\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NY Times<\/span><\/a> <span style=\"font-weight: 400;\">).<\/span><\/p>\n\n<h3 class=\"wp-block-heading\" id=\"epidemiological-evidence\">Pr\u00e8v Epidemyolojik<\/h3>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Yo sijere plizy\u00e8 teyori sou kijan antitranspiran ak dezodoran ka lak\u00f2z kans\u00e8 nan tete. D\u00e8nye revizyon sou antitranspiran oswa dezodoran ak kans\u00e8 nan tete pa montre okenn pr\u00e8v pou yon lyen (Osto 2022). Sepandan, etid yo rap\u00f2te rezilta melanje, kidonk plis etid neses\u00e8 pou konfime done akty\u00e8l yo.  <\/span><\/p>\n\n<p class=\"wp-block-paragraph\"><br\/><span style=\"font-weight: 400;\">Sosyete Ameriken pou Kans\u00e8 a te note ke pandan yon etid an 2004 te montre prezans parab\u00e8n nan tisi kans\u00e8 nan tete, yo pwodui pwopriyete ki sanble ak estwoj\u00e8n ki f\u00e8b. Estwoj\u00e8n ki pwodui natir\u00e8lman nan k\u00f2 a (oswa atrav\u00e8 ranplasman \u00f2m\u00f2n) pi f\u00f2, e pakonsekan jwe yon<\/span> <a href=\"https:\/\/www.cancer.org\/healthy\/cancer-causes\/chemicals\/antiperspirants-and-breast-cancer-risk.html\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">w\u00f2l pi gwo<\/span><\/a> <span style=\"font-weight: 400;\">nan risk kans\u00e8 nan tete.<\/span><\/p>\n\n<p class=\"wp-block-paragraph\"><br\/><span style=\"font-weight: 400;\">Sij\u00e8 sa a te atire atansyon an 2021 l\u00e8 yon etid te rap\u00f2te ke yo te jwenn parab\u00e8n, yon pr\u00e9servatif yo itilize nan dezodoran ki imite estwoj\u00e8n, nan tim\u00e8 nan tete. Syantis yo pa s\u00e8ten sa etid sa a vle di sou devlopman kans\u00e8 nan tete (<\/span> <a href=\"https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/myths\/antiperspirants-fact-sheet\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCI<\/span><\/a> <span style=\"font-weight: 400;\">).<\/span><\/p>\n\n<h3 class=\"wp-block-heading\" id=\"laboratory-evidence\/supporting\">Pr\u00e8v Laboratwa\/Pr\u00e8v Sip\u00f2<\/h3>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Yon etid sou b\u00e8t ki te egzamine abs\u00f2psyon aliminy\u00f2m nan dezodoran te jwenn k\u00e8k pr\u00e8v<\/span> <span style=\"font-weight: 400;\">kraze kwomoz\u00f2m ( <a href=\"https:\/\/www.mdpi.com\/1422-0067\/22\/17\/9515\" target=\"_blank\" rel=\"noopener\">Tenan et al.<\/a> )<\/span> <span style=\"font-weight: 400;\">. Sepandan, rech\u00e8ch akty\u00e8l la toujou limite. Plis rech\u00e8ch neses\u00e8 pou envestige plis relasyon ki genyen ant antitranspiran ak risk kans\u00e8.<\/span><\/p>\n\n<h3 class=\"wp-block-heading\" id=\"iarc-carcinogen-classification\">Klasifikasyon kanseroj\u00e8n IARC:<span style=\"font-weight: 400;\"> <\/span><\/h3>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Pa klase<\/span><\/p>\n\n<h2 class=\"wp-block-heading\" id=\"how-to-reduce-your-risk\">Kijan pou diminye risk ou<\/h2>\n\n<p class=\"wp-block-paragraph\">Gen anpil fakt\u00e8 risk li te ye ki lye av\u00e8k kans\u00e8 nan tete. Bw\u00e8 alk\u00f2l gen yon lyen kl\u00e8 av\u00e8k yon ogmantasyon risk pou kans\u00e8 nan tete, epi risk la ogmante av\u00e8k kantite alk\u00f2l la. Fanm ki bw\u00e8 yon bwason ki gen alk\u00f2l pa jou gen yon ti ogmantasyon (7-10%) konpare ak moun ki pa bw\u00e8. Risk sa a ogmante a 20% nan fanm ki bw\u00e8 2-3 bwason pa jou ( <a href=\"https:\/\/www.cancer.org\/cancer\/breast-cancer\/risk-and-prevention\/lifestyle-related-breast-cancer-risk-factors.html\" target=\"_blank\" rel=\"noopener\">ACS<\/a> ).   <\/p>\n\n<p class=\"wp-block-paragraph\"><br\/>Yon l\u00f2t fakt\u00e8 risk byen koni se l\u00e8 yon fanm gen tw\u00f2p pwa oswa li ob\u00e8z apre menopoz. Sitou apre yon fanm rive nan menopoz, pif\u00f2 estwoj\u00e8n yon fanm soti nan tisi gr\u00e8s. Tw\u00f2p gr\u00e8s ka ogmante nivo estwoj\u00e8n epi ogmante risk pou kans\u00e8 nan tete. Fanm apre menopoz ki gen tw\u00f2p pwa oswa ki ob\u00e8z yo gen tandans gen pi wo nivo ensilin tou, ki lye av\u00e8k k\u00e8k kans\u00e8. Fakt\u00e8 risk sa yo ka diminye av\u00e8k aktivite fizik ak yon rejim alimant\u00e8 ki an sante, ki diminye risk pou kans\u00e8 nan tete ( <a href=\"https:\/\/www.cancer.org\/cancer\/breast-cancer\/risk-and-prevention\/lifestyle-related-breast-cancer-risk-factors.html\" target=\"_blank\" rel=\"noopener\">ACS<\/a> ).    <\/p>\n\n<h2 class=\"wp-block-heading\" id=\"bottom-line\">Liy final la<\/h2>\n\n<p class=\"wp-block-paragraph\">Deodoran ak antitranspiran pafwa gen engredyan ki lye ak kans\u00e8. Sepandan, gen k\u00e8k etid sou antitranspiran ki bay rezilta kontradiktwa, kidonk plis rech\u00e8ch neses\u00e8. <\/p>\n\n<p class=\"wp-block-paragraph\">Pou gade yon ti videyo sou dezodoran ak risk kans\u00e8 nan tete, klike anba a.<\/p>\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"Can Deodorant Cause Cancer?\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/8V13vnMFrRE?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Sa ou ka tande Antitranspiran ak dezodoran gen sibstans ki lak\u00f2z kans\u00e8 epi ki abs\u00f2be, sitou apre ou fin f\u00e8 bab. Sa syans di nou Antitranspiran yo klase k\u00f2m yon medikaman ki ede diminye kantite swe ki pwodui. Glann ekrin lan pwodui swe epi antitranspiran yo ka bloke pwodiksyon swe a l\u00e8 l s\u00e8vi av\u00e8k&hellip;<\/p>\n","protected":false},"author":1,"featured_media":9660,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[553],"tags":[514],"class_list":["post-6965","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pwodwi-konsomate-yo","tag-definitivman-oubyen-pwobableman-pa-vre"],"acf":[],"_links":{"self":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts\/6965","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/comments?post=6965"}],"version-history":[{"count":11,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts\/6965\/revisions"}],"predecessor-version":[{"id":13764,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts\/6965\/revisions\/13764"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/media\/9660"}],"wp:attachment":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/media?parent=6965"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/categories?post=6965"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/tags?post=6965"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}